Hostname: page-component-6bf8c574d5-xtvcr Total loading time: 0 Render date: 2025-02-16T17:46:54.483Z Has data issue: false hasContentIssue false
  • English
  • Français

Women and Substance Abuse: Health Considerations and Recommendations

Published online by Cambridge University Press:  01 February 2011

Nassima Ait-Daoud  and
Mudhasir Bashir
Get access Rights & Permissions [Opens in a new window]

Abstract

There has been growing evidence in recent years of the importance of gender specific issues in the addiction field. This paper explores specific problems and including specific health consequences faced by women who drink or use drugs. We describe helpful screening tools that can be used in the primary care setting and offer an understanding of some of the barriers preventing women from seeking help. This article also provides guidance on the best pharmacotherapy and psychological interventions that can be used to help women recover from their addiction.

Type
Review Article
Information
CNS Spectrums , Volume 16 , Issue 2 , February 2011 , pp. 37 - 47
Copyright
Copyright © Cambridge University Press 2012

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

Faculty Disclosures: Dr. Ait-Daoud has received research grants from the NIAAA and the NIDA. Dr. Bashir reports no affiliations with or financial interests in any organization that may pose a conflict of interest.

Off-label Usage: This article includes discussion of the following unapproved medications for the treatment of alcohol and other substance use disorders: topiramate, ondansetron, fluoxetine and sertraline.

References

Faculty Disclosures: Dr. Ait-Daoud has received research grants from the NIAAA and the NIDA. Dr. Bashir reports no affiliations with or financial interests in any organization that may pose a conflict of interest.

Off-label Usage: This article includes discussion of the following unapproved medications for the treatment of alcohol and other substance use disorders: topiramate, ondansetron, fluoxetine and sertraline.